Interview Guidance Program (IGP) for UPSC CSE 2024, Registrations Open Click Here to know more and registration
News: An old drug formulation RLF-100 or Aviptadil is being probed to treat Covid-19 patients after initial studies have shown that the drug is able to halt SARS-CoV-2 virus replication in lungs.
Facts:
- RLF-100 or Aviptadil: It is an old proprietary drug formulation of synthetic human Vasoactive Intestinal Polypeptide(VIP).
Additional Facts:
- Vasoactive Intestinal Polypeptide (VIP): It is released throughout the body but remains mostly concentrated in lungs.
- Significance of VIP:
- It is produced by immune cells and nerve endings and acts as a neurotransmitter.
- It helps improve muscle activity and blood flow in the gastrointestinal tract.
- It has anti-inflammatory and anti-cytokine activity properties that can help in alleviating respiratory distress in COVID19 patients.
Discover more from Free UPSC IAS Preparation Syllabus and Materials For Aspirants
Subscribe to get the latest posts sent to your email.
